RSNA: Protons Destroy Centrally Located Lung Cancer

Using image-guided hypofractionated treatments to eradicate centrally located non-small-cell lung cancers (NSCLCs), Bradford Hoppe, MD, of the University of Florida Health in Jacksonville, reported a 3-year overall survival rate of 84% for the 16 patients included in the study who had been treated between 2008 and 2015 -- a rate that is at least as good as other reports in the literature for such centrally located lesions, he said at the annual meeting of the Radiological Society of North America.

To read more please visit http://www.medpagetoday.com/meetingcoverage/rsna/61833

Source: Medpage Today